Brief: Janux Announces Doses Selected For Phase 1B Expansion Trials

Janux Therapeutics

02/12/2024 22:21

Dec 2 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX ANNOUNCES DOSES SELECTED FOR PHASE 1B EXPANSION
TRIALS
SUPPORTED BY ENCOURAGING EFFICACY AND SAFETY PROFILE OBSERVED IN
PHASE 1A DOSE ESCALATION FOR JANX007 IN MCRPC

Source text:  ID:nBw7zkq3ha 
Further company coverage:  JANX.O 

 ((Reuters.Briefs@thomsonreuters.com;))